Chart Industries sells LNG process tech to MAIRE for $220M amid Baker Hughes deal review
Read source articleWhat happened
Chart Industries agreed to sell its natural gas liquefaction process technologies, including over 90 patents and proprietary know-how, to MAIRE's NextChem for $220 million. The sale likely represents a required divestiture to address antitrust concerns surrounding Baker Hughes' pending $13.6 billion acquisition of Chart. Baker Hughes announced the acquisition in July 2025 to strengthen its cryogenic and LNG offerings, and this divestiture trims a portion of that portfolio. The deal is small relative to the overall transaction, representing less than 2% of the acquisition price, and may smooth regulatory approval. Investors should monitor whether this is an isolated divestiture or signals broader concessions that could reduce the strategic value of the Chart deal.
Implication
The sale of LNG process technologies to MAIRE suggests Baker Hughes is addressing competitive overlap in LNG engineering, which could expedite antitrust clearance. Over the long term, losing these patents may slightly reduce Baker Hughes' technology exclusivity in LNG, but the $220 million price tag is negligible compared to the $13.6 billion deal. The core value of Chart lies in cryogenic equipment and systems, not just process licensing, so the impact on synergies is limited. However, investors should watch for additional divestitures that could erode the strategic rationale. Overall, this development does not change the fundamental thesis that Baker Hughes is fully valued at current levels with execution risk around the Chart integration.
Thesis delta
The divestiture of LNG process technologies does not alter the core investment thesis. It may reduce regulatory risk slightly, but the fundamental concerns about valuation, cyclical OFSE weakness, and Chart integration remain. Therefore, the thesis remains unchanged: a hold-or-trim with limited upside at current prices.
Confidence
High